Acquire the license to the best health content in the world
Contact Us

Clinical Trials Update: March 27, 2008

Peripheral Neuropathy Urticaria Down Syndrome

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Peripheral Neuropathy

Candidates 18 or older with type 1 or type 2 diabetes, with pain greater than four on a pain scale of 0-11 for seven consecutive days may be eligible for this study.

The research site is in Salisbury, N.C.

More information

Please see http://www.centerwatch.com/patient/studies/cat709.html.

-----

Urticaria

If your child is aged 1 to 5 with allergic rhinitis documented by a positive skin prick test or RAST performed within the last six months, and the child is a candidate for antihistamine treatment or has received an antihistamine in the past, the child may qualify for this study.

The research site is in El Paso, Texas.

More information

Please see http://www.centerwatch.com/patient/studies/cat811.html.

-----

Down Syndrome

Candidates with trisomy 21 down syndrome, mild-to-moderate cognitive dysfunction, aged 10 to 17, residing in the community with a caregiver, and having no unstable health conditions may be eligible for this study.

The research site is in Toledo, Ohio.

More information

Please see http://www.centerwatch.com/patient/studies/cat512.html.

-----

Copyright 2008 Thomson CenterWatch. All rights reserved.

Consumer News